Skip to main content
. 2017 Mar 8;12:1853–1862. doi: 10.2147/IJN.S131235

Figure 2.

Figure 2

(A) Cytotoxicity of DOX-based combinations (DOX/TPL-1/0.05, 1/0.1, 1/0.2, 1/0.5, and 1/1) against KB cells after incubation for 48 h (n=4). (B) Plot of the combination index as the function of cell viability for KB cells treated with free DOX and free TPL combinations.

Abbreviations: DOX, doxorubicin; TPL, triptolide.